Tumors associated with p53 germline mutations: A synopsis of 91 families

American Journal of Pathology

Volumn 150, Issue 1, 1997, Pages 1-13

  Kleihues, Paul ^a,b   Schäuble, Barbara ^b   Zur Hausen, Axel ^b   Estève, Jacques ^a   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADRENAL CORTEX CARCINOMA; AGE; BRAIN TUMOR; BREAST CARCINOMA; CARCINOGENESIS; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; GENE MUTATION; HODGKIN DISEASE; HUMAN; MALIGNANT TRANSFORMATION; OSTEOSARCOMA; PRIORITY JOURNAL; REVIEW; SEX RATIO; SOFT TISSUE SARCOMA; TUMOR SUPPRESSOR GENE;

DISEASE SUSCEPTIBILITY; GENES, P53; HUMANS; MUTATION; NEOPLASMS;

EID: 0031031049     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bishoff FZ, Tainsky MA: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990, 250:1233-1238
2. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH: Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990, 348:747-749
3. Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J: Anaplastic Wilms' tumor' a subtype displaying poor prognosis, harbours p53 gene mutations. Nature Genet 1994, 7:91-97
4. Birch JM, Hartley AL, Tricker KJ, Presser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D, Craft AW, Eden OB, Evans GR, Thompson E, Mann JR, Martin J, Mitchell, Santibanez-Koref MF: Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994, 54: 1298-1304
5. Børresen AL, Andersen TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjord J, Ottestad L, Smith-Sørensen B, Hovig E, Malkin D, Friend SH: Screening for germ line TP53 mutations in breast cancer patients. Cancer Res 1992, 52:3234-3236
6. Brugieres L, Gardes M, Moutou C, Chompret A, Meresse V, Martin A, Poisson N, Flamant F, Bonaiti-Pellie C, Lemerle J, Feunteun J: Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. Cancer Res 1993, 53:452-455
7. Coles C, Condie A, Chetty U, Steel CM, Evans HJ, Presser J: p53 mutations in breast cancer. Cancer Res 1992, 52:5291-5298
8. Diller L, Sexsmith E, Gottlieb A, Li FP, Malkin D: Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 1995, 95:1606-1611
9. Eeles RA, Warren W, Knee G, Bartek J, Averill D, Stratton MR, Blake PR, Tait DM, Lane DP, Easton DF, Yarnold JR, Cooper CS, Sloane JP: Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. Oncogens 1993, 8:1269-1276
10. Felix CA, Nau MM, Takahashi T, Mitsudomi T, Chiba I, Poplack DG, Reaman GH, Cole DE, Letterio JJ, Whang Peng J, Knutsen T, Minna JD: Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest 1992, 89:640-647
11. Felix CA, Strauss EA, D'Amico D, Tsokos M, Winter S, Mitsudomi T, Nau MM, Brown DL, Leahey AM, Horowitz ME, Poplack DG, Costin D, Minna JD: A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. Oncogene 1993, 8:1203-1210
12. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher IM, Bron L, Benhattar J, Tada M, Van Meir EG, Estreicher A, Iggo RD: A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 1995, 92:3963-3967
13. Frebourg T, Barbier N, Van Y, Garber JE, Dreyfus M, Fraumeni JJ, Li FP, Friend SH: Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 1995, 56:608-615
14. Grayson GH, Moore S, Schneider BG, Saldivar V, Hensel CH: Novel germline mutation of the p53 tumor suppressor gene in a child with incidentatty discovered adrenal cortical carcinoma. Am J Pediatr Hematol Oncol 1994, 16:341-347
15. Gutierrez MI, Bhatia KG, Barreiro C, Spangler G, Schvartzmann E, Muriel FS, Magrath IT: A de novo p53 germline mutation affecting codon 151 in a six-year-old child with multiple tumors. Hum Mol Genet 1994, 3:2247-2248
16. Hamelin R, Barichard F, Henry I, Junien C, Thomas G: Single base pair germ-line deletion in the p53 gene in a cancer predisposed family. Hum Genet 1994, 94: 88-90
17. Horio Y, Suzuki H, Ueda R, Koshikawa T, Sugiura T, Ariyoshi Y, Shimokata K, Takahashi T: Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. Oncogene 1994, 9:1231-1235
18. Iavarone A, Matthay KK, Steinkirchner TM, Israel MA: Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma. Proc Natl Acad Sci USA 1992, 89:4207-4209
19. Jolly KW, Malkin D, Douglass EC, Brown TF, Sinclair AE, Look AT: Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogens 1994, 9:97-102
20. Kovar H, Auinger A, Jug G, Muller T, Pillwein K: p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree. Oncogene 1992, 7:2169-2173
21. Kyritsis AP, Bondy ML, Xiao M, Berman EL, Cunningham JE, Lee PS, Levin VA, Saya H: Germline p53 gene mutations in subsets of glioma patients. J Natl Cancer Inst 1994, 86:344-349
22. Law JC, Strong LC, Chidambaram A, Ferrel RE: A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res 1991, 51:6385-6387
23. Lübbe J, von Ammon K, Watanabe K, Hegi ME, Kleihues P: Familial brain tumor syndrome associated with a p53 germline deletion of codon 236. Brain Pathol 1995, 5:15-23
24. Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Borresen AL, Li FP, Garber J, Strong LC: Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 1992, 326:1309-1315
25. Mazoyer S, Lalle P, Moyret-Laile C, Marcais C, Schraub S, Frappaz D, Sobol H, Ozturk M: Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations. Oncogene 1994, 9:1237-1239
26. McIntyre JF, Smith Sørensen B, Friend SH, Kassell J, Borresen AL, Yan YX, Russo C, Sato J, Barbier N, Miser J, Malkin D, Gebhardt MC: Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 1994, 12:925-930
27. Metzger AK, Sheffield VC, Duyk G, Daneshvar L, Edwards MS, Cogen PH: Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma. Proc Natl Acad Sci USA 1991, 88:7825-7829
28. Plummer SJ, Santibanez Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton Culver H, Casey G: A germline 2.35 kb deletion of p53 genomic DMA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family. Oncogene 1994, 9:3273-3280
29. Porter DE, Holden ST, Steel CM, Cohen BB, Wallace MR, Reid R: A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families. J Bone Joint Surg Br 1992, 74:883-886
30. Prosser J, Porter D, Coles C, Condie A, Thomson AM, Chetty U, Steel CM, Evans HJ: Constitutional p53 mutation in a non-Li-Fraumeni cancer family, Br J Cancer 1992, 65:527-528
31. Russo CL, McIntyre J, Goorin AM, Link MP, Gebhardt MC, Friend SH: Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations. Med Pediatr Oncol 1994, 23: 354-358
32. Sameshima Y, Tsunematsu Y, Watanabe S, Tsukamoto T, Kawa-ha K, Hirata Y, Mizoguchi H, Sugimura T, Terada M, Yokota J: Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. J Natl Cancer Inst 1992, 84:703-707
33. Santibanez Koref MF, Birch JM, Hartley AL, Jones PH, Craft AW, Eden T, Crowther D, Kelsey AM, Harris M: p53 germline mutations in Li-Fraumeni syndrome. Lancet 1991, 338:1490-1491
34. Scott RJ, Krummenacher F, Mary JL, Weber W, Spycher M, Muller H: Vererbbare p53-Mutation bei einem Patienten mit Mehrfachtumoren: Bedeutung fur die genetische Beratung [Hereditary p53 mutation in a patient with multiple tumors: significance for genetic counseling]. Schweiz Med Wochenschr 1993, 123:1287-1292
35. Shiseki M, Nishikawa R, Yamamoto H, Ochiai A, Sugimura H, Shitara N, Sameshima Y, Mizoguchi H, Sugimura T, Yokota J: Germ-line p53 mutation is uncommon in patients with triple primary cancers. Cancer Lett 1993, 73:51-57
36. Sidransky D, Tokino T, Helzsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B, Davidson N: Inherited p53 gene mutations in breast cancer. Cancer Res 1992, 52:2984-2986
37. Stolzenberg MC, Brugieres L, Gardes M, Dessarps Freichey F, Chompret A, Bressac B, Lenoir G, Bonaiti Pellie C, Lemerle J, Feunteun J: Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family. Oncogene 1994, 9:2799-2804
38. Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera GE, Ishizaki K, Yamamuro T, Meyers PA, Little JB, Sasaki MS, Weichselbaum RR, Yandell DW: Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 1992, 326:1301-1308
39. Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA, Malkin D: High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst 1994, 86:1707-1710
40. Warneford SG, Witton LJ, Townsend ML, Rowe PB, Reddel PR, Dalla-Pozza L, Symonds G: Germ-line splicing mutation of the p53 gene in a cancer-prone family. Cell Growth Differ 1992, 3:839-846
41. Li FP, Fraumeni JF Jr: Soft-tissue sarcomas, breast cancer, other neoplasms: a familial syndrome? Ann Intern Med 1969, 71:747-752
42. Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW: A cancer family syndrome in twenty-four kindreds. Cancer Res 1988, 48:5358-5362
43. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF Jr, Li FP: Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 1991, 51:6094-6097
44. Birch JM, Hartley AL, Blair V, Kelsey AM, Harris M, Teare MD, Jones PH: Cancer in the families of children with soft tissue sarcoma. Cancer 1990, 66:2239-2248
45. Ohgaki H, Eibl RH, Schwab M, Reichel MB, Mariani L, Gehring M, Petersen I, Höll T, Wiestler OD, Kleihues P: Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinogen 1993, 8:74-80
46. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54:4855-4878
47. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS, Little JB, Weichselbaum RR, Ishizaki K, Yandell DW: Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 1992, 52: 6194-6199
48. Felix CA, Kappel CC, Mitsudomi T, Nau MM, Tsokos M, Crouch GD, Nisen PD, Winick NJ, Helman LJ: Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res 1992, 52:2243-2247
49. McGee JO, Isaacson PG, Wright NA (Eds): Oxford Textbook of Pathology, vol 1: General Principles of Pathology. Oxford, Oxford University Press, 1992
50. Lantos PL, VandenBerg SR, Kleihues P: Tumors of the nervous system. Greenfield's Neuropathology, vol 2, ed 6, ch 9. Edited by PI Graham, PL Lantos. London, Arnold (in press)
51. Mirra JM: Bone Tumors: Clinical, Radiologic and Pathologic Correlations. Philadelphia, Lea & Febiger, 1989
52. Barzilay JI, Pazianos AG: Adrenocortical carcinoma. Urol Clin North Am 1989, 16:457-468
53. Enzinger FM, Weiss SW: Soft Tissue Tumors, St Louis, Mosby, 1994
54. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H: Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas, Brain Pathol 1996, 6:217-224
55. Isselbacher KJ: Harrison's Principles of Internal Medicine. New York, McGraw-Hill, 1994
56. Wooster R, Neuhausen SL, Mangton J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-AI-bright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994, 265:2088-2090
57. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE: Risks of cancer in BRCA1-mutation carriers: Breast Cancer Linkage Consortium, Lancet 1994, 343:692-695
58. Szabo CI, King MC: Inherited breast and ovarian cancer. Hum Mol Genet 1995, 4:1811-1817
59. La Spada AR, Paulson HL, Fischbeck KH: Trinucleotide repeat expansion in neurological disease. Ann Neurol 1994, 36:814-822
60. Almasan A, Linke SP, Paulson TG, Huang LC, Wahl GM: Genetic instability as a consequence of inappropriate entry into and progression through S-phase. Cancer Metastasis Rev 1995, 14:59-73
61. Weinert T, Lydall D: Cell cycle checkpoints, genetic instability and cancer. Semin Cancer Biol 1993, 4:129-140
62. Malkin D: p53 and the Li-Fraumeni syndrome. Biochim Biophys Acta 1994, 1198:197-213
63. Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A: High incidence of lung, bone, lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 1989, 9:3982-3991
64. Donehower LA, Harvey M, Vogel H, McArthur MJ, Montgomery CA Jr, Park SH, Thompson T, Ford RJ, Bradley A: Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinogen 1995, 14:16-22
65. Louis DN: The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 1994, 53:11-21
66. Ohgaki H, Schäuble B, zur Hausen A, von Ammon K, Kleihues P: Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch 1995, 427:113-118
67. Collins VP: Gene amplification in human gliomas. Glia 1995, 15:289-296
68. Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends Genet 1993, 9:138-141
69. Boschman CR, Stryker S, Reddy JK, Rao MS: Expression of p53 protein in precursor lesions and adenocar- cinoma of human pancreas. Am J Pathol 1994, 145: 1291-1295
70. DiGiuseppe JA, Hruban RH, Offerhaus GJ, Clement MJ, van den Berg FM, Cameron JL, van Mansfeld AD: Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994, 144:889-895
71. el Naggar AK, Lai S, Luna MA, Zhou XD, Weber RS, Goepfert H, Batsakis JG: Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int J Cancer 1995, 64:196-201
72. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS: p53 tumor suppressor gene mutations in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 1994, 54:4342-4346
73. Wang LD, Hong JY, Qiu SL, Gao H, Yang CS: Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 1993, 53:1783-1787
74. Harris CC, Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 1994, 330:864-865
75. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 1991, 253:49-53
76. Montesano R, Hollstein M, Hainaut P: Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996, 69:225-235
77. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Benichou J, Dai Q, Fraumeni JF Jr: Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer 1994, 58:192-196
78. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM, Rabbitts P: p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 1992, 7:1989-1997
79. Sozzi G, Miozzo M, Donghi R, Pilottl S, Cariani CT, Pastorino U, Della Porta G, Pierotti MA: Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 1992, 52:6079-6082
80. Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M, De Gregorio L, Manenti G, Radice P, Mineletti F, Delia Porta G, Pierotti MA: Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res 1995, 55:135-140
81. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Russell SE: Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Cancer Res 1995, 55:3406-3411
82. Tohdo H, Yokozaki H, Hamura K, Kajiyama G, Tahara E: p53 gene mutations in gastric adenomas. Virchows Arch B Cell Pathol 1993, 63:191-195
83. Quo WD, Chow WH, Zheng W, Li JY, Blot WJ: Diet, serum markers, and breast cancer mortality in China. Jpn J Cancer Res 1994, 85:572-577
84. Bentivegna SS, Bresnick E: Inhibition of human O6-methylguanine-DNA methyltransferase by 5-methylcytosine. Cancer Res 1994, 54:327-329
85. Ohshima H, Bartsch H: Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994, 305: 253-264
86. Laird PW, Jaenisch R: DNA methylation and cancer. Hum Mol Genet 1994, 3:1487-1495
87. Shen JC, Zingg JM, Yang AS, Schmutte C, Jones PA: A mutant Hpall methyltransferase functions as a mutator enzyme. Nucleic Acids Res 1995, 23:4275-4282
88. Shen JC, Rideout WMI, Jones PA: High frequency mutagenesis by a DNA methyltransferase. Cell 1992, 71: 1073-1080
89. Yang AS, Shen JC, Zingg JM, Mi S, Jones PA: Hhal and Hpall DNA methyltransferases bind DMA mismatches, methylate uracil, and block DMA repair. Nucleic Acids Res 1995, 23:1380-1387
90. Cho Y, Gorina S, Jeffrey PD, Pavletich NP: Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 1994, 265:346-355
91. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA: Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994, 4:1-7
92. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R, Harris CC: Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 1996, 24: 141-146